• Monday, Aug 08, 2022
  • Last Update : 04:24 pm

Unilever to buy 82% stake of GlaxoSmithKline BD

  • Published at 09:05 pm March 23rd, 2020
web-uniliver
Unilever headquarters in Rotterdam, Netherlands August 21, 2018 Reuters

General and institutional investors own the rest 18% shares in the GSK Bangladesh

Unilever Overseas Holdings B.V (Unilever) will buy  9,875,144 shares or 82% stakes in GlaxoSmithKline's health food and drinks business in Bangladesh for Tk 1,640 crore.

General and institutional investors own the rest 18% shares in the GSK Bangladesh, a listed company, according to a disclosure posted yesterday on the Dhaka Stock Exchange (DSE) website.


As per the disclosure, "Sale of entire shareholding of SETFIRST Limited (Setfirst)", a shareholder of the Company holding 9,875,144 shares, has further informed that the sale shares held by Setfirst in the Company will be acquired by "Unilever Overseas Holdings B.V" instead of "Unilever N.V".


Each share of the GSK Bangladesh, which was listed on the DSE in 1976, closed at Tk 2046.30 each on Monday.